1
|
Stegemann S, Sheehan L, Rossi A, Barrett A, Paudel A, Crean A, Ruiz F, Bresciani M, Liu F, Shariff Z, Shine M, Schmelzer C, Pense-Lheritier AM. Rational and practical considerations to guide a Target Product Profile for patient-centric drug product development with measurable patient outcomes - A proposed roadmap. Eur J Pharm Biopharm 2022; 177:81-88. [PMID: 35718077 DOI: 10.1016/j.ejpb.2022.06.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 06/12/2022] [Accepted: 06/13/2022] [Indexed: 11/29/2022]
Abstract
The increasing awareness of acceptability and usability of pharmaceutical drug products by the patient as a key quality requirement continues to drive need for integrating patient centric drug product design into the pharmaceutical development process. The complex matrix of multiple drug product related decisions during the early drug development process often limits patient-centric drug product (PCDP) design options in the final commercial drug product development phase. To integrate the specific needs and perspectives of patients into drug development and product design process, a rational approach integrated into the complex development matrix is required from the start and weighs product development decision options accordingly. The aim of this work was to develop a roadmap for PCDP design in a multidisciplinary approach that leads to better usability, adherence and acceptance of the drug by patients via early integration into the development matrix. The proposed rational approach is based upon regulatory requirements and lessons learned from pediatric and geriatric drug development.
Collapse
Affiliation(s)
- Sven Stegemann
- Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria.
| | - Liz Sheehan
- SRL, Office of Technology 2-44, Western Gateway Building, University College Cork, Ireland.
| | - Alessandra Rossi
- Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
| | - Andrew Barrett
- Drug Product Design, Pharmaceutical Sciences, Pfizer, Discovery Park House, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.
| | - Amrit Paudel
- Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
| | - Abina Crean
- SSPC Pharmaceutical Research Centre, School of Pharmacy, University College Cork, Cork, Ireland.
| | - Fabrice Ruiz
- ClinSearch, 110 Avenue, Pierre Brossolette, 92240 Malakoff, France.
| | - Massimo Bresciani
- CMAC Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow G1 1RD, UK.
| | - Fang Liu
- Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK.
| | - Zakia Shariff
- School of Pharmacy, Aston University, Birmingham, B4 7ET, UK.
| | - Margarete Shine
- SRL, Office of Technology 2-44, Western Gateway Building, University College Cork, Ireland.
| | | | | |
Collapse
|
4
|
Moriarty M, Maher M, Morton G, Flavin A, Mooney E, Neilan J, Nestor P, Horgan PG, Kerin M, Waldron D, Gannon F, Given H, McCann AH, Dervan PA, Codd MB, Guillick WJ, Carney DN, Horgan PG, O’Brien DP, Waldron DJ, Mooney E, McGuire M, Given HF, Dolan J, O’Hora A, Droogan O, Curran B, Henry K, Leader M, Meehan S, Magee H, Carney D, Dervan P, Lawler M, McCann SR, Humphries P, Barrett J, O’Sullivan G, Collins JK, Williams N, Daly J, Herlyn M, Corbally N, Sweeney E, Dervan P, Carney DN, Sheppard MN, Hamid Q, Corrin B, Weedle RM, Cotter TG, Wilkinson YA, McKenna PG, Hahnvajanawong C, O’Sullivan G, McCarthy M, Collins JK, Atkinson RJ, Pedlow P, McQuaid S, Johnson P, Stuart J, O’Meara A, Russell SEH, White PM, Atkinson RJ, Hickey GI, Pomeroy M, Prosser E, Barker F, Casey M, Carroll K, O’Kennedy R, Duffy G, Fennelly JJ, Duffy MJ, Reilly D, Fennelly JJ, O’Higgins N, Rochfort H, O’Neal KL, Hoper M, Odling-Smee GW, Abram WP, McKenna PG, Mooney E, Brougham C, Horgan P, Waldron D, O’Brien D, Kerin M, Heyden DR, Given HF, Lanigan D, McLean P, Murphy D, Donovan MG, Curran B, Leader M, Martin A, Clynes M, Graham D, Curran B, McQuaid S, Dorman T, Breathnach F, Fitzgerald RJ, Leader M, O’Meara A, Lennon SV, Martin SJ, Cotter TG, Ryan L, Kilfeather SA, O’Malley K, Nolan KB, Croke DT, Helene C, Browne PV, Lawler M, McCann SR, Clarke E, McCann SR, Glynn J, Cotter K, Shine M, Cotter T, Sweeney E, Dervan P, Carney DN, McKelvey VJ, Stefani LAJ, McKenna PG, Ranjbar S, Cromie E, Eason S, Hannigan BM, Corbett A, O’Sullivan G, Collins JK, O’Brien F, O’Sullivan G, Collins JK, Carney DN, Grogan L, Leonard N, Morton G, Flavin A, Moriarty M, Foley-Nolan D, McCann A, Carney DN, Fennelly JJ, Jones M, Garrett C, Pomeroy M, Brennan DP, Powell D. Irish association for cancer research. Ir J Med Sci 1991. [DOI: 10.1007/bf02947640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|